Jorge Matias-Guiu
0000-0001-8162-9043
Complutense University of Madrid
3 papers found
Refreshing results…
Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab
Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
Should We Adapt the Prescription Criteria for Specific Treatments for Migraine Due to the COVID‐19 Pandemic?
Missing publications? Search for publications with a matching author name.